- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/445 - Plasmodium
Patent holdings for IPC class C07K 14/445
Total number of patents in this class: 334
10-year publication summary
|
29
|
21
|
29
|
29
|
10
|
13
|
7
|
14
|
16
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Institut Pasteur | 789 |
14 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2842 |
11 |
| Var2 Pharmaceuticals ApS | 13 |
10 |
| Oxford University Innovation Limited | 1497 |
8 |
| The Walter and Eliza Hall Institute of Medical Research | 170 |
7 |
| Board of Trustees of the University of Arkansas | 787 |
6 |
| The Hospital for Sick Children | 417 |
6 |
| Rhode Island Hospital | 192 |
6 |
| The Texas a & M University System | 1602 |
6 |
| Washington University | 1543 |
6 |
| Glaxosmithkline Biologicals S.A. | 1700 |
5 |
| The United States of America as represented by the Secretary of the Navy | 2726 |
5 |
| The Trustees of the University of Pennsylvania | 4262 |
5 |
| Seattle Children's Hospital, d/b/a Seattle Children's Research Institute | 115 |
5 |
| BioNTech SE | 579 |
5 |
| Centre National de La Recherche Scientifique | 10124 |
4 |
| University of South Florida | 1830 |
4 |
| Seattle Children's Hospital | 68 |
4 |
| Osivax SAS | 12 |
4 |
| Abbott Laboratories | 2460 |
3 |
| Other owners | 210 |